The reason may be described that in NAFLD mice, insulin resistance is distinct, and the effect of insulin to inhibit lipolysis of adipose tissue is weakened, which leads to increased delivery of free fatty acids to the hepatocytes [38, 39]. The gene discussed is INS; the disease is metabolic dysfunction-associated steatotic liver disease.